Tomonori Ishii - Concepedia

Author

Tomonori Ishii

Also Known As

Ishii Tomonori, Ishii, Tomonori, Ryota Sakai, T Ishii, T. ISHII, T. Ishii, TOMONORI ISHII, Tomonori ISHII, Tomonori Ishii, Yasuhiko Hirabayashi

242

Publications

5.6K

Citations

H-Index

119

Concepts

All Affiliations

Tohoku University Tohoku University Hospital University of Occupational and Environmental Health Japan Keio University Hokkaido University

About

Tomonori Ishii is an author at Tohoku University specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	29	1.5K
2	Allergy	3	3	110
3	Health Sciences	2	2	80
4	Public Health	2	2	70
5	Natural Sciences	1	1	11

Tomonori Ishii

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, The Lancet Respiratory Medicine Autoimmune DiseaseSystemic SclerodermaImmunologySystemic SclerosisMultiple Sclerosis	2020	612
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study) Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei, Annals of the Rheumatic Diseases	2017	369
Human parvovirus B19 as a causative agent for rheumatoid arthritis Yuichi Takahashi, Chihiro Murai, S Shibata, Proceedings of the National Academy of Sciences	1998	274
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection Yasuhiko Munakata, Takako Saito‐Ito, Keiko Kumura-Ishii, Blood	2005	177
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO Tomonori Ishii, Kei Ohnuma, Akikazu Murakami, Proceedings of the National Academy of Sciences	2001	172
Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study Norihiro Nishimoto, Koichi Amano, Yasuhiko Hirabayashi, Modern Rheumatology	2013	119
A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese Yukinori Okada, Kenichi Shimane, Yuta Kochi, PLoS Genetics	2012	118
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation Hideto Ikushima, Yasuhiko Munakata, Tomonori Ishii, Proceedings of the National Academy of Sciences ImmunologyImmune RegulationBinding ProteinImmunologic MechanismAntigen Processing	2000	117
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study Yoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, Lara D. Veeken	2019	111
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial Dinesh Khanna, Yannick Allanore, Christopher P. Denton, Annals of the Rheumatic Diseases	2020	104

Page 1